跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 1,749 条关于
“PAR2”
全部
1,749
临床试验
1,488
药物
88
机构
53
资讯
120
去年
Domain Therapeutics to Showcase Novel GPCR-Targeting Oncology Programs at AACR 2025
6个月前
SolasCure's Aurase Wound Gel Demonstrates 22x Faster Debridement in Phase II Chronic Wound Trial
7个月前
Kainova Therapeutics Raises $32M CAD to Advance GPCR-Targeting Cancer and Inflammation Therapies
9个月前
FoRx Therapeutics Secures $50M Series A to Advance PARG Inhibitor for PARP-Resistant Cancers
5年前
Comparative Analysis of PARP Inhibitors in BRCA-Mutated Ovarian Cancer Shows Similar Efficacy and Toxicity
6年前
PARP Inhibitors Show Similar Efficacy in BRCA-Mutated Ovarian Cancer, Cost-Effectiveness Varies
去年
PARP Inhibitor Niraparib Shows Breakthrough Results in Mesothelioma Treatment
去年
Genomic Scarring Score Predicts PARP Inhibitor Response in NSCLC
4年前
PARP Inhibitors Show Promise in Ovarian Cancer Maintenance Therapy
12年前
Niraparib Maintenance Therapy Demonstrates Sustained Benefit in Recurrent Ovarian Cancer
第 1 页,共 12 页
上一页
下一页